Shin Nippon Biomedical Laboratories, Ltd. - Net Worth and Insider Trading
Shin Nippon Biomedical Laboratories, Ltd. Net Worth
The estimated net worth of Shin Nippon Biomedical Laboratories, Ltd. is at least $12 Million dollars as of 2024-11-05. Shin Nippon Biomedical Laboratories, Ltd. is the 10% Owner of Satsuma Pharmaceuticals Inc and owns about 11,217,845 shares of Satsuma Pharmaceuticals Inc (STSA) stock worth over $12 Million. Details can be seen in Shin Nippon Biomedical Laboratories, Ltd.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Shin Nippon Biomedical Laboratories, Ltd. has not made any transactions after 2023-06-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Shin Nippon Biomedical Laboratories, Ltd.
Shin Nippon Biomedical Laboratories, Ltd. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Shin Nippon Biomedical Laboratories, Ltd. owns 2 companies in total, including WAVE Life Sciences Ltd (WVE) , and Satsuma Pharmaceuticals Inc (STSA) .
Insider Ownership Summary of Shin Nippon Biomedical Laboratories, Ltd.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| WVE | WAVE Life Sciences Ltd | 2015-11-10 | 10 percent owner |
| STSA | Satsuma Pharmaceuticals Inc | 2023-06-08 | 10 percent owner |
Shin Nippon Biomedical Laboratories, Ltd. Latest Holdings Summary
Shin Nippon Biomedical Laboratories, Ltd. currently owns a total of 1 stock. Shin Nippon Biomedical Laboratories, Ltd. owns 11,217,845 shares of Satsuma Pharmaceuticals Inc (STSA) as of June 8, 2023, with a value of $12 Million.
Latest Holdings of Shin Nippon Biomedical Laboratories, Ltd.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| STSA | Satsuma Pharmaceuticals Inc | 2023-06-08 | 11,217,845 | 1.10 | 12,339,630 |
Holding Weightings of Shin Nippon Biomedical Laboratories, Ltd.
Shin Nippon Biomedical Laboratories, Ltd. Form 4 Trading Tracker
According to the SEC Form 4 filings, Shin Nippon Biomedical Laboratories, Ltd. has made a total of 1 transactions in Satsuma Pharmaceuticals Inc (STSA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Satsuma Pharmaceuticals Inc is the acquisition of 30,477,313 shares on June 8, 2023, which cost Shin Nippon Biomedical Laboratories, Ltd. around $28 Million.
Insider Trading History of Shin Nippon Biomedical Laboratories, Ltd.
- 1
Shin Nippon Biomedical Laboratories, Ltd. Trading Performance
Shin Nippon Biomedical Laboratories, Ltd. Ownership Network
Ownership Network List of Shin Nippon Biomedical Laboratories, Ltd.
Ownership Network Relation of Shin Nippon Biomedical Laboratories, Ltd.
Shin Nippon Biomedical Laboratories, Ltd. Owned Company Details
What does WAVE Life Sciences Ltd do?
Who are the key executives at WAVE Life Sciences Ltd?
Shin Nippon Biomedical Laboratories, Ltd. is the 10 percent owner of WAVE Life Sciences Ltd. Other key executives at WAVE Life Sciences Ltd include See Remarks Chris Francis , director & See Remarks Paul Bolno , and 10 percent owner Plc Glaxosmithkline .
WAVE Life Sciences Ltd (WVE) Insider Trades Summary
Over the past 18 months, Shin Nippon Biomedical Laboratories, Ltd. made no insider transaction in WAVE Life Sciences Ltd (WVE). Other recent insider transactions involving WAVE Life Sciences Ltd (WVE) include a net sale of 69,838 shares made by Kyle Moran , a net purchase of 6,091,930 shares made by Plc Glaxosmithkline , and a net purchase of 2,000,000 shares made by Ra Capital Healthcare Fund Lp .
In summary, during the past 3 months, insiders sold 364,822 shares of WAVE Life Sciences Ltd (WVE) in total and bought 2,791,930 shares, with a net purchase of 2,427,108 shares. During the past 18 months, 417,514 shares of WAVE Life Sciences Ltd (WVE) were sold and 8,091,930 shares were bought by its insiders, resulting in a net purchase of 7,674,416 shares.
WAVE Life Sciences Ltd (WVE)'s detailed insider trading history can be found in Insider Trading Tracker table.
WAVE Life Sciences Ltd Insider Transactions
Shin Nippon Biomedical Laboratories, Ltd. Mailing Address
Above is the net worth, insider trading, and ownership report for Shin Nippon Biomedical Laboratories, Ltd.. You might contact Shin Nippon Biomedical Laboratories, Ltd. via mailing address: 2438 Miyanoura-machi, Kagoshima City, Kagoshima M0 891-1394.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
